Table 1.
Demographic and clinical characteristics of study participants.
| HC (n = 71) | LC (ARC, n = 103) | LC (NASH, n = 5) | |
|---|---|---|---|
| Age, years | 49.9 (10.9) | 57.6 (10.9) | 57.8 (4.8) |
| Sex, number of males (%) | 44 (62%) | 77 (75%) | 3 (60%) |
| MELD Score | 12 (8–14) | 13 (13–14) | |
| Haemoglobin, g/L | 131.5 (121.8–142.3) | 132 (110–137) | |
| Platelet count, x109/L | 113 (87–175.8) | 108 (100–124) | |
| INR | 1.2 (1.1–1.4) | 1.4 (1.4–1.5) | |
| Bilirubin, μmol/l | 28 (13–36.3) | 36 (29–38) | |
| AST, IU/ml | 34 (24–48.8) | 38 (33–49) | |
| ALP, IU/ml | 113.5 (89.5–152) | 120 (110–147) | |
| GGT, IU/l | 85 (41.8–151) | 73 (60–84) | |
| Albumin, g/L | 39 (34–45.3) | 31 (29–32) | |
| Creatinine, μmol/l | 74 (62.8–95.3) | 80 (65–97) |
All data is presented as median (IQR), except for age, which is shown as mean (SD).
Healthy control (HC), Liver cirrhosis (LC), Alcohol-related cirrhosis (ARC), Non-alcoholic liver steatohepatitis (NASH); Standard deviation (SD), Model of end stage liver disease score (MELD), Aspartate Transaminase (AST); Alkaline Phosphatase (ALP), Gamma-glutamyl Transferase (GGT).